FIELD: pharmacology.
SUBSTANCE: invention relates to glucosylceramide synthase (GCS) inhibitors of formula
,
as well as to a method for treatment with these compounds.
EFFECT: new compounds are obtained which can be used to treat a disease of lysosomal accumulation, wherein the said lysosomal accumulation disease is the result of a defect in the glycosphingolipid pathway.
33 cl, 20 dwg, 1 tbl, 127 ex
Title | Year | Author | Number |
---|---|---|---|
COLONY-STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS | 2016 |
|
RU2748884C2 |
BICYCLIC DERIVATIVES | 2019 |
|
RU2794894C2 |
BENZAMIDE COMPOUNDS | 2019 |
|
RU2801647C2 |
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
BICYCLIC DERIVATIVES | 2019 |
|
RU2794895C2 |
INDANOL DERIVATIVES | 2005 |
|
RU2323937C1 |
MMPL3 INHIBITORS, COMPOSITIONS BASED ON THEM AND WAYS OF THEIR APPLICATION | 2019 |
|
RU2795229C2 |
CHIRAL MYRTANYL SULPHONAMIDES | 2019 |
|
RU2725878C1 |
WATER-SOLUBLE ANALOGUES CC-1065 AND THEIR CONJUGATES | 2007 |
|
RU2489423C2 |
PESTICIDE COMPOSITIONS | 2010 |
|
RU2550352C2 |
Authors
Dates
2018-02-27—Published
2012-03-16—Filed